Fentanyl sublingual - Ethypharm

Drug Profile

Fentanyl sublingual - Ethypharm

Alternative Names: Fentanyl citrate sublingual tablets - Ethypharm; Fentanyl Ethypharm; Fentanyl sublingual tablets - Ethypharm; Recivit

Latest Information Update: 06 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ethypharm
  • Developer Ethypharm; Grunenthal
  • Class General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer pain

Most Recent Events

  • 08 Aug 2013 Biomarkers information updated
  • 22 Sep 2012 Ethypharm completes a phase III trial in Cancer pain in Czech Republic (EudraCT2011-001140-30)
  • 07 Oct 2011 Phase-III clinical trials in Cancer pain in Czech Republic (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top